Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.

Blood - 15 Jun 2005

Rocha Jose Claudio C, Cheng Cheng, Liu Wei, Kishi Shinji, Das Soma, Cook Edwin H, Sandlund John T, Rubnitz Jeffrey, Ribeiro Raul, Campana Dario, Pui Ching-Hon, Evans William E, Relling Mary V

Abstract excerpt

Acquired genetic characteristics of acute lymphoblastic leukemia (ALL) cells are used to individualize therapy, whereas germ line genetic characteristics generally are not. We determined whether ALL outcome was related to 16 genetic polymorphisms affecting the pharmacodynamics of antileukemic age...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Disease-Free Survival
Share to Glutathione Transferase
Share to Pharmacogenetics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Receptors, Calcitriol

Share to Recurrence

Share to Remission Induction

Share to Thymidylate Synthase

Source

Open in PubMed Open full text

Identifiers

PMID: 15713801
DOI: 10.1182/blood-2004-11-4544
PMCID: PMC1895006

Genes

TYMS
GSTM1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-15713801-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics of outcome in children with acute lymphoblastic leukemia.PMID 15713801Read ↗

Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Pharmacogenetic considerations for acute lymphoblastic leukemia therapies.Semantic proximity Read ↗

Implementation of Pharmacogenetics to Individualize Treatment Regimens for Children with Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Pharmacogenetics in acute lymphoblastic leukemia.Semantic proximity Read ↗

Pharmacogenetic determinants of outcome in acute lymphoblastic leukaemia.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase polymorphisms and therapy response in pediatric acute lymphoblastic leukemia.Semantic proximity Read ↗

Pharmacogenetic Predictors of Treatment-Related Toxicity Among Children With Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.Semantic proximity Read ↗

Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group.Semantic proximity Read ↗

Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy.Semantic proximity Read ↗

Genomic profiling of thousands of candidate polymorphisms predicts risk of relapse in 778 Danish and German childhood acute lymphoblastic leukemia patients.Semantic proximity Read ↗

How can we improve on the already impressive results in pediatric ALL?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.